ShareValue scores for 600624.SHG: Valuation 36, Quality 8, Growth 46, Health 48.

600624.SHG
SSE

Shanghai Fudan Forward S&T Co Ltd

CN¥3.95(-0.25%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-9% to 13%
Valuation
36
Overvalued
Price vs Value
Quality
8
Weak
Business Strength
Growth
46
Moderate
Revenue & Earnings
Health
48
Moderate
Financial Stability
Momentum
12
Bearish
Price Trend

Company Details

About

Shanghai Fudan Forward S&T Co., Ltd engages in the medical and health, digital economy, high-tech, and other businesses. The company is involved in the research and development, production, and sales of computer systems, communication equipment, automation instruments, biotechnology, light source lighting, and other products; and import and export business. It also engages in the research and development, production, and sales of chemical raw materials, chemical pharmaceutical preparations, and traditional Chinese medicine; exporting software to Japan in the fintech sector; and development, construction, operation, and management of high-tech parks. In addition, the company provides investment and consulting services in the high-tech field; distributes car audio and high-end car care products; processes sheet metals; and develops health management systems. Further, it focuses on specialized drugs and specialty drugs; and digestive system drugs, nervous system drugs, anti-tumor drugs, circulatory system drugs, etc., as well as injectable glutathione, shuangyiping tablets, flutamide tablets, isosorbide dinitrate tablets, and other products. Shanghai Fudan Forward S&T Co., Ltd was founded in 1984 and is based in Shanghai, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026